Why Function Health pulled ahead
A membership with 100+ lab tests, all results in one place. The model and its real costs.
Full answer in the decktest longevity page
LAST UPDATED: September 7, 2026
The longevity market, mapped in one deck
Who's raising, who's winning, which business models make money, and what could break it. Every slide answers one question.
Get the market reportRead by people at
BlackstonecitiFidelity
mastercardSamsungHYUNDAI
Why we built this deck
Longevity is a hard market to read. The science is solid in places and thin in others, the clinics don't publish their revenue or their retention, insurers rarely reimburse any of it, and half the coverage online is a funding press release with a headline on top.
The reports on sale aren't much better. You get a market size with no method behind it, figures from two years ago, and paragraphs about the growing consumer appetite for healthspan that an AI could have written in four seconds.
So we read the funding announcements, the clinic pricing pages, the FDA clearances, the published trials and the forums where people argue about their blood panels. Every figure names its source. When two sources disagree, we explain the gap instead of averaging it. When the data is thin, we say so. And every quarter, we do the whole thing again.
Some of the questions we answer inside
Six examples, out of 210 slides.
Where Retro's $1B is actually going
The biggest cheque in the market went into cell reprogramming. What it buys, and who followed.
Full answer in the deck
Why doctors say skip the tests
Doctor skepticism stops more sales than price. The objections, and who answered them.
Full answer in the deck
Calico and Altos Labs, years in
Two of the best-funded labs in the field, still nothing on the market. What that means.
Full answer in the deck
Who pays when insurers won't
Preventive panels are rarely reimbursed. Who pays instead, and for how long.
Full answer in the deck
What Whoop bought with Ronaldo
Wearables went from step counts to the recovery data longevity programs run on.
Full answer in the deckThe 12 sections
In longevity, the science, the money and the buyer rarely point the same way: a therapy can be promising and unsellable, a clinic profitable and unproven. These twelve sections are the angles we needed to make sense of it, from what counts as longevity at all to who ends up paying.
- Market definitionWhere longevity ends and wellness begins: clinics, diagnostics and therapeutics in, generic fitness out.
- Market opportunityHow a biohacker niche became a category where Retro raises $1B and Whoop signs Cristiano Ronaldo.
- Market sizeA first-principles estimate you can defend, instead of the ten contradictory numbers floating online.
- Pain pointsWhat keeps clinics, insurers and health-conscious buyers stuck, scored from annoying to deal-breaker.
- Tech & infraFrom at-home blood panels to AI health coaches: what's live, what's in beta, what's still a promise.
- Value creationMemberships, clinician-led programs, test bundles: which models hold margins and which burn cash.
- Market challengesRegulation, weak evidence, hype backlash: each risk rated by how much it could slow the market.
- Growth driversAging populations are the obvious one. The less-discussed drivers decide how fast this really grows.
- Investor betsWhich longevity theses still get funded, which stopped exciting VCs, and what's picking up now.
- Top playersBeyond Calico and Altos Labs: the quieter startups, mapped by segment and business model.
- Startup killersOverpromising, no validation plan, the wrong buyer: patterns from longevity startups that failed.
- Startup strategiesWhat Function Health and the category leaders did to earn trust, capital and repeat customers.
How one slide is built
Every page of the deck follows the same four rules.
- One question per slideWeeks of research compressed into a single view you read in seconds
- Sources on the slideNamed at the bottom of each page, with full URLs at the end of the deck
- Refreshed every quarterFigures rechecked, new rounds added, the date printed on the cover
- No false precisionWhen sources disagree we explain why, and we flag where the data is thin
Questions?
What exactly do I get?
A 210+ slide PDF, downloadable right after checkout. Sources are cited on each slide, with full URLs at the end.
Do I get future updates?
We rewrite every deck each quarter. Choose the one-year option and each new edition lands in your inbox, along with the funding database.
Who is this report for?
Founders, investors, operators and strategists who need a clear view of the market before they build, invest, partner or reposition.
What do you include in the longevity market?
Products and services that use science, medicine or technology to extend healthy years of life: therapies, diagnostics, clinics, digital tools and programs. Generic wellness, beauty, fitness and eldercare are out.
What's in the funding database?
Every longevity round we track, with the amount, the stage, the date and the investors. It comes as a spreadsheet, refreshed each quarter.
Can I get an invoice for my company?
Yes. Add your company name at checkout, or email us and we'll send one.
Is this a one-time payment?
Yes. No subscription, nothing renews.
Still have a question?
Email team@newmarketpitch.com and we reply within 24 hours.
Get the longevity market report
Same deck. Decide whether you want it to stay current.
The deck
September 2026 edition
$99one-time
- All 12 sections, 210+ slides
- Instant PDF download
- Questions answered by our team
- Quarterly updates for a year
- Longevity funding database
For people who need it up to date
The deck + future updates
Updates and data for 12 months
$149one-time
- All 12 sections, 210+ slides
- Instant PDF download
- Questions answered by our team
- Every quarterly rewrite for a year
- Our longevity funding database: every deal we track, with amounts, stages and investors, refreshed each quarter
Use code MARKETPITCH for 10% off your order